Exploring the role of brain-derived extracellular vesicles in viral infections: from pathological insights to biomarker potential
Larise Oberholster1 
Renaud Du Pasquier
Amandine Mathias- 1Laboratory of Neuroimmunology, Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland
- 2Service of Neurology, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland
Extracellular vesicles (EVs) are membrane-bound vesicles secreted by all cell types that play a central role in cell-to-cell communication. Since these vesicles serve as vehicles of cellular content (nucleic acids, proteins and lipids) with the potential to cross biological barriers, they represent a novel attractive window into an otherwise inaccessible organ, such as the brain. The composition of EVs is cell-type specific and mirrors the physiological condition of the cell-of-origin. Consequently, during viral infection, EVs undergo significant changes in their content and morphology, thereby reflecting alterations in the cellular state. Here, we briefly summarize the potential of brain-derived EVs as a lens into viral infection in the central nervous system, thereby: 1) uncovering underlying pathophysiological processes at play and 2) serving as liquid biopsies of the brain, representing a non-invasive source of biomarkers for monitoring disease activity. Although translating the potential of EVs from research to diagnosis poses complexities, characterizing brain-derived EVs in the context of viral infections holds promise to enhance diagnostic and therapeutic strategies, offering new avenues for managing infectious neurological diseases.
1 Introduction
Extracellular vesicles (EVs) are membranous structures that are secreted by all cell types and that are found in all body fluids, as well as tissue culture supernatants (van Niel et al., 2018). While the term `extracellular vesicles` is used to annotate all cell-derived membrane-delimited vesicles, these structures are highly divergent and can be divided into two main groups, namely exosomes and microvesicles, that are characterized based on their biogenesis, content, morphology, and functional atributes (van Niel et al., 2018). Exosomes, referred to as small EVs, are the most widely studied and comprise a size distribution ranging from 30 nm to 150 nm (Johnstone et al., 1987). Exosomes arise from the inward budding of early endosomes that enables formation of intraluminal vesicles (ILVs) within multivesicular endosomes (MVEs) (Harding et al., 1984). MVEs can fuse with the plasma membrane, releasing the ILVs, now referred to as exosomes, into the extracellular space (Pan et al., 1985; Doyle and Wang, 2019). Contrary to exosomes, microvesicles bud directly from the plasma membrane into the extracellular environment and have a size distribution ranging from 100 nm to 1000 nm (Tricarico et al., 2017). While, historically characterized as means of eliminating cellular waste (Johnstone et al., 1987), it is now established that EVs play a critical role in intercellular communication, transporting cellular components such as microRNAs, mRNAs, and DNAs, lipids and proteins, in both physiological and diseased conditions (Colombo et al., 2014; Lo Cicero et al., 2015; Yanez-Mo et al., 2015; van Niel et al., 2018). The transfer of these molecules via EVs can have a range of effects on recipient cells, including alteration of gene expression, modulation of signaling pathways, induction of phenotypic changes, and influence on the cellular behavior (Raposo et al., 1996; Valadi et al., 2007; van Niel et al., 2018). The composition of EVs is cell type-specific and determined by the physiological state of the cell, along with environmental stimuli (Minciacchi et al., 2015). Here, we compile evidence for the potential of EVs to enhance our understanding of the brain and its associated disease mechanisms, particularly in the context of viral infections. Additionally, we will briefly review the challenging potential of EVs as new disease biomarkers.
2 EVs from health to infection
2.1 EVs in the brain during physiological conditions
The central nervous system (CNS), being comprised of highly divergent populations of neuronal or glial cells generated in a spatiotemporal manner, stands as one of the most intricate structures in the body. The importance of EVs in intercellular communication in the CNS has been extensively characterized (Fruhbeis et al., 2012; Kramer-Albers and Hill, 2016). EVs might have a central role in neural development (Edlund and Jessell, 1999; Bahram Sangani et al., 2021) by harboring neurodevelopmental signaling proteins with the capacity to induce neural progenitor proliferation and differentiation as demonstrated in vitro and in vivo in developing mouse neural models (Sharma et al., 2019). Moreover, EVs were also found to have neuroprotective function(s) by assisting in the clearance of β-amyloid from the CNS in vivo (Yuyama et al., 2014), or to protect human brain endothelial cells from oxidative stress as shown in vitro (Liu et al., 2017). EVs also have a role in maintaining and enhancing synaptic plasticity (Graykowski et al., 2020). Neuron-derived EVs were found to contain synaptic proteins and upon internalization by cultured neurons, promoted dendritic spine formation through BDNF-TrkB-mediated signaling. Moreover, these neuron-derived EVs were able to preserve neuronal complexity during nutrient deprivation (Solana-Balaguer et al., 2023).
2.2 EVs and viral infection
Besides their involvement in normal physiological conditions in the brain, EVs have also been implicated in mediating a pathological effect on recipient cells. Indeed, mounting evidence suggests a close link between EVs and viruses, as viruses often rely on the same cellular machinery involved in EV biogenesis for their own replication and release into the extracellular milieu (Bello-Morales et al., 2020). Viruses may even utilize EVs as a means of propagation to neighboring cells (Moulin et al., 2023). Viruses typically categorized as non-enveloped, such as hepatitis A virus (HAV) (Feng et al., 2013), Coxsackievirus (Robinson et al., 2014), rotavirus and norovirus (Santiana et al., 2018) have been demonstrated to be enclosed within membrane vesicles when secreted by cells. The encapsulation of multiple virions/genomes within a single EV allows for the delivery of a higher multiplicity of infection, thereby increasing the possibility of productive infection and enabling the replacement of faulty proteins or particles (Troyer and Tilton, 2021). Moreover, the physical encapsulation by EVs also offers protection against neutralizing antibodies as has been reported for herpes simplex virus 1 (HSV-1) (Heilingloh et al., 2015; Bello-Morales et al., 2018), HAV (Feng et al., 2013), Hepatitis C virus (HCV) (Ramakrishnaiah et al., 2013), and Hepatitis E virus (HEV) (Nagashima et al., 2014).
On the other hand, EVs play a crucial role in regulating viral infections by serving as carriers of viral components or immunomodulatory molecules that can have either a pro- or anti-viral effect on recipient cells (Perez et al., 2019). For instance, EVs released by HIV-1 infected primary CD4+ T lymphocytes were shown to deliver negative factor protein (Nef) to nearby cells, licensing them for viral infection (Arenaccio et al., 2014). Conversely, EVs can also serve as carriers of anti-viral mediators such as human cytidine deaminase APOBEC3G, known for its role in cellular defense against retrovirus (Khatua et al., 2009) or, stimulator of interferon genes (STING), which can activate the innate immune response against viruses like HSV-1, limiting viral spread (Deschamps and Kalamvoki, 2018). Similarly, EVs containing viral nucleic acids, such as HCV RNA (Dreux et al., 2012) or Epstein-Barr virus (EBV) polymerase III-transcribed noncoding RNAs (EBERs) (Baglio et al., 2016) can induce an innate immune response in recipient cells.
Understanding how EVs facilitate or hinder viral entry, replication or spread relies heavily on the precise isolation of these two populations. However, due to their similar size and buoyant density, separating EVs from free virions presents a significant hurdle (Arakelyan et al., 2017; Kutchy et al., 2020). Techniques for separation include targeting EV specific membrane proteins (CD63, CD9, CD81) on the surface of EVs (Thery et al., 2018; Welsh et al., 2024), or exploiting the migration differences between EVs and viruses using Iodixanol velocity gradient (Konadu et al., 2016). Nevertheless, assessing EV purity from virus-infected cells is challenging as the border between EVs and some enveloped viruses remains ill-defined (Nolte-’t Hoen et al., 2016). Nonetheless, new technics such as high-throughput flow cytometry may enable future discrimination of EV and virus particles (Nolte-’t Hoen et al., 2012; Arakelyan et al., 2015).
3 Neurotropic viruses and EV hijacking: example of brain infections
Examining EVs in the context of viral infection might shed light into disease mechanisms, particularly in inaccessible organs such as brain. Here, we focus on selected viruses that can invade the CNS and the role of EVs in their interaction with CNS target cells.
3.1 Flaviviruses
The unique evolutionary advantages offered by EVs have also been harnessed by neurotrophic viruses belonging to the family of Flaviviridae. This includes Zika virus (ZIKV), which have received major attention for its propensity to evoke serious neurological injury during the early stages of human development (Brasil et al., 2016). Furthermore, major progress has been achieved using mouse and non-human primate models, revealing that ZIKV circumvents host cellular machinery through a mechanism referred to as the “secretory autophagy” or “exosome pathway” process that may facilitate viral vertical transmission from trophoblast to fetal cells during pregnancy (Cugola et al., 2016; Zhang et al., 2017; Wu et al., 2023). To further elucidate the role of EVs in ZIKV infection within the developing fetal brain, EVs from cultured ZIKV-infected mouse neurons were analyzed for viral content and potential to mediate viral infection to uninfected cortical neurons (Zhou et al., 2019). EVs from infected cells were shown to comprise ZIKV RNA and proteins that were highly infectious and resistant to RNase activity and antibody neutralization treatment. In the same study, ZIKV was shown to induce both the activity and gene expression of neutral sphingomyelinase SMPD3 (nSMase2) in cortical neurons. This induction facilitated infection and transmission of ZIKV through EVs, potentially leading to severe neuronal death. Such neuronal damage may result in neurological manifestations, such as microcephaly, in the developing embryonic brains (Zhou et al., 2019). Similar observations were done on EVs derived from Japanese Encephalitis virus (JEV) -infected microglial cells which, upon internalization by neurons, induced caspase activation and neuronal injury (Mukherjee et al., 2019).
3.2 Herpesviruses
HSV-1, a prevalent neurotropic virus, typically infects sensory neurons, traveling to trigeminal ganglia through retrograde axonal transport (Marcocci et al., 2020; Zhu and Viejo-Borbolla, 2021). In rare cases, the virus can infect the brain parenchyma, particularly the temporal lobes, causing a herpes simplex meningo-encephalitis (Marcocci et al., 2020). EVs from HSV-1-infected human oligodendroglial HOG cells were shown to propagate viral infection to Chinese hamster ovary (CHO) cells, which are normally resistant to free virions, suggesting a role for EVs in broadening HSV-1 tropism and viral immune evasion (Bello-Morales et al., 2018). More recently, EVs from HSV-1-infected epithelial cells were demonstrated to exhibit an upregulation of proteins with the capacity to promote neurite outgrowth and subsequent viral spread to neurons (Sun et al., 2024).
3.3 Human Immunodeficiency Virus (HIV)
EVs might also contribute to the neurotoxicity associated with cognitive impairment in patients suffering from acquired immunodeficiency syndrome. In a study investigating the impact of opiate drug abuse on the progression of HIV-associated neurocognitive disorder, EVs derived from astrocytes treated with HIV tat protein and morphine was shown to contain an increased level of miR-29b. Upon uptake by human neuronal cell lines in culture, this heightened miR-29b content led to neuronal death through the targeting and downregulation of platelet-derived growth factor-B (PDGFB) expression (Hu et al., 2012). Furthermore, EVs from HIV tat-exposed primary human fetal astrocytes contained increased levels of miR-7 that induced synaptic injury through the downregulation of neuronal neuroligin 2 (NLGN2) in recipient neurons (Hu et al., 2020). In a separate study, HIV Nef protein was found to associate with microglia-derived EVs and, using an in vitro model of the blood-brain barrier (BBB), was shown to compromise the permeability and integrity of the BBB (Raymond et al., 2016). Moreover, these Nef-containing EVs triggered the upregulation of Toll-like receptor-induced cytokines and chemokines, suggesting a role of Nef-containing vesicles in neuroinflammation and subsequent CNS injury observed during HIV-associated neurocognitive disorder (HAND) (Raymond et al., 2016). Additionally, exposure of neurons to Nef-containing astrocyte EVs resulted in the suppression of neuronal action potential and induction of oxidative stress and neurotoxicity (Sami Saribas et al., 2017).
3.4 Polyomaviruses
Recent studies have focused on the involvement of EVs in the dissemination of JC polyomavirus (JCPyV) in the CNS. JCPyV is the causative agent of progressive multifocal leukoencephalopathy, a severe demyelinating disease of the CNS that results in the formation of lesions across the brain parenchyma (Padgett et al., 1971; Cortese et al., 2021). We have recently shown that JCPyV alters the proteomic content of EVs from infected human induced pluripotent stem-cell derived astrocytes, which resulted in a signature highly reflective of infected cells, yet starkly different from that of EVs generated under inflammatory, non-viral, conditions (Oberholster et al., 2023). The involvement of EVs in the in vitro propagation of JCPyV has been demonstrated in different cell types, suggesting an alternative route of dissemination beyond the conventional release of free virus particles (Morris-Love et al., 2019; Morris-Love et al., 2022). Moreover, it was demonstrated that EVs from JCPyV-infected choroid plexus epithelial cells were able to transmit viral infection to naïve glial cells that lacked the alleged viral attachement receptor, namely lactoseries tetrasaccharide c (O’Hara et al., 2020). These data suggest that JCPyV infection could be, at least partially, independent of the virus attachment receptor. Furthermore, JCPyV VP1 capsid protein and genomic DNA of the archetype sequence was found to associate with plasma derived EVs from HIV patients, suggesting a potential role for EVs in JCPyV spread in vivo and entry into the CNS (Scribano et al., 2020). However, due to limitations in modeling JCPyV infection in the brain, the significance of EVs in the dissemination of JCPyV within the CNS remains unclear.
Interestingly, since the contents of EVs from infected or healthy cells differ profoundly in their composition (Meckes et al., 2013; Oberholster et al., 2023), EVs offer a promising avenue for understanding the complex mechanisms at play in the context of viral infection in the brain. This, in turn, might pave the way toward the development of innovative diagnostic tools and therapeutic interventions targeting neurological diseases.
4 EVs as a source of biomarkers for neurological diseases
Identifying biomarkers for neurological diseases, including those that result from viral infections, is especially challenging as most neurodegenerative disorders are confined to 1) an inaccessible organ, 2) a distinct region of the brain and 3) a particular subset of cells. However, various CNS cell types have been demonstrated to secrete EVs, including oligodendrocytes, neurons and astrocytes (Bakhti et al., 2011; Wu et al., 2017), suggesting that brain-derived EVs in body fluids could offer a non-invasive means of obtaining a representation of the entire brain and sustain new biomarker characterization.
Indeed, EVs offer multiple advantages as a unique source of new biomarkers due to their specificity, stability, ability to cross biological barriers and non-invasive sampling. Because the contents of EVs are shielded from degradation by DNases, RNases, and proteases, the characterization of EVs isolated from any biofluid allows for the identification of robust biomarkers, as opposed to the analysis of plain blood, urine, or CSF (Boukouris and Mathivanan, 2015).
The potential of EVs to cross biological barriers, including the BBB, has opened avenues in which CNS-derived EVs found in the CSF and in the blood could serve as non-invasive means to gain valuable insights into the physiological state of the brain (Ramos-Zaldivar et al., 2022). In patients with Parkinson’s disease (PD), multiple system atrophy (MSA) or progressive supranuclear palsy (PSP), plasma levels of oligodendrocyte- and neuron-derived EVs were shown to be increased compared to disease control group (Ohmichi et al., 2019). In AD patients, as compared to patients with frontotemporal dementia, neuron-derived blood exosomes were found to have higher levels of lysosome-associated membrane protein 1 (LAMP1) and cathepsin D (Goetzl et al., 2015). Another study found that astrocyte-derived EVs contained elevated levels of classical and alternative complement pathway proteins in AD patients as compared to matched controls (Goetzl et al., 2018). Furthermore, the analysis of EVs might enable the enrichment of low abundant proteins that are normally masked by high abundant ones, such as albumin, in crude biofluids (Upadhya et al., 2020). Yet, protein composition within EVs can be influenced by various factors, such as sample handling and storage conditions, necessitating standardized isolation and detection methods.
Among other cargos, nucleic acids encapsulated within EVs, including microRNAs (miRNAs), or messenger RNAs (mRNAs), and DNA fragments, have been demonstrated to reflect disease-specific molecular signatures, facilitating early detection and monitoring of disease progression such as mainly reported in the context of neurodegeneration (Raghav et al., 2022; Lim et al., 2023) or primary CNS tumors (Zhang et al., 2023; Hallal et al., 2024). Despite being an attractive source of EV-associated biomarkers, accurate EV-RNA/DNA quantitation faces key challenges due to low yields, influenced by sample source and isolation methods, further impacting data interpretation (Hill et al., 2013; Saugstad et al., 2017; Gandham et al., 2020). Overcoming these hurdles will be essential for reliable EV RNA/DNA characterization, particularly in disease diagnosis and therapeutic development.
Lipids associated with EVs, even if less studied to date especially as potential biomarkers, also may play pivotal roles in cellular signaling and neurotransmission within the CNS. Alterations in lipid profiles of CNS EVs may signify cellular dysfunction and disease progression, offering novel avenues for biomarker discovery such as envisioned in PD or AD (Vanherle et al., 2020). However, comprehensive lipidomic analysis of EVs requires specialized equipment and expertise further hindering transfer into routine laboratory testing as diagnosis or prognostic markers.
Another challenge in approaching CNS specific biomarkers is establishing tissue-specific EV isolation technics. To isolate brain-derived EVs from the blood, current strategies are typically based on immunoprecipitation techniques that utilize antibodies targeting cell-type specific markers: oligodendrocyte-myelin glycoprotein (MOG) for oligodendrocytes, neural cell adhesion molecule L1 (L1CAM) for neurons, and glutamate aspartate transport protein (GLAST) for astrocytes. However, the reliability of these markers for isolating ‘brain-derived’ EVs has been questioned, as these markers are also widely expressed by cells outside the CNS (Kramer-Albers and Hill, 2016). Furthermore, in vitro studies have suggested that these markers may not consistently be incorporated into EVs (Norman et al., 2021; You et al., 2022). Nonetheless, since brain-derived EVs in the periphery might present a real-time source of information relevant to non-accessible organ such as the brain, efforts are underway to identify new brain cell-type specific membrane makers. Research about EVs as a diagnostic tool for viral infectious diseases is still in its early stages, yet it holds significant promise. CSF EVs derived from glial cells, neurons and the choroid plexus of patients with HIV-associated neurocognitive disorders were shown to comprise proteins involved in stress responses and immune/inflammatory responses, suggesting their potential as a source of biomarkers to neurological disease activity (Guha et al., 2019). In another study, plasma neuron-derived EVs from HIV-positive patients with neurological complications showed an enrichment of neurofilament-light chain (NFL), high mobility group box 1 (HMGB1) and amyloid beta (Aβ) proteins as compared to controls (Sun et al., 2017). More recently, neuron-derived EVs isolated from patients experiencing long term effects of coronavirus disease 2019 (COVID-19) were found to contain elevated levels of proteins indicative of neuronal damage as compared to pre-COVID-19 controls (Tang et al., 2024). As such, neuron-derived EVs might provide a non-invasive source of biomarkers to identify cognitive impairment related to HIV-infection. Similarly, plasma-derived EVs expressing the astrocytic marker, glial fibrillary acidic protein (GFAP), were significantly increased in patients suffering from HAND as compared to patients with normal cognition, further supporting the relevance of brain-derived EVs as indicators of neuronal injury (de Menezes et al., 2022).
Finally, the translation of EV research into clinical applications is a concern, particularly regarding their potential as a novel source of biomarkers. Indeed, before EVs can be widely accepted as disease biomarkers, it is imperative to overcome the technical challenges posed by their isolation, characterization, methodological standardization, and reporting (Van Deun et al., 2017; Roux et al., 2020; Welsh et al., 2024). The chosen method for isolating EVs significantly affects both sample yield and purity. Currently, there is no unified standard for exosome separation and purification. Indeed, it exists various methods including differential ultracentrifugation (UC), density gradient ultracentrifugation (DGUC), size exclusion chromatography (SEC), filtration, precipitation or immune-based extraction or more recently microfluidic approaches; each of those have their advantages and limitations (Xu et al., 2016; He et al., 2022). Technical challenges in isolating EVs consistently, along with complex analysis techniques, may hinder their use as powerful biomarkers. Pre- and post-analytical variability can also impact the presence of non-vesicular particles together with the surface and content of specific EVs (Clayton et al., 2019; Buzas, 2022; Görgens et al., 2022). Prioritizing reproducibility and ease-of-use is crucial for effective biomarker discovery in any diseases. All these challenges are currently addressed. Guidelines and position papers have been recently published for blood and CSF (Hendrix, 2021; Lucien et al., 2023; Sandau et al., 2024). Resolving these challenges is essential for harnessing the full diagnostic potential of EVs in clinical settings.
5 Discussion
The intricate relationship between EVs and viruses operates on multiple levels. EVs might serve as a vehicle of viral propagation. Moreover, transported viral or cellular content might evoke distinct responses in recipient cells (Figure 1A). As per virus point-of view, these responses can either be advantageous, priming cells for infection, or detrimental, hindering viral replication. Nevertheless, our comprehension of the role of EVs in viral infection, especially those pertaining to the CNS, remains incomplete, primarily because of the difficulty of isolating single cell specific EVs in vivo. While significant insights have been gained through cell culture models, the complexity of the CNS cellular composition and microenvironment is not fully captured yet. Similarly, while animal models offer valuable insights into EV dynamics in a physiological context, they may fail to mimic certain developmental or pathological features that are unique to humans, including specific human host-pathogen interactions (Figure 1A) (Bárbara and Sónia, 2017; Swearengen, 2018). To address these challenges, future research should focus on developing more physiologically relevant in vitro human models, such as organoid cultures or microfluidic systems, that better mimic the complexity of the CNS microenvironment (Figure 1B). The capacity of EVs to cross biological barriers, including the BBB, means that brain-derived EVs could be identified in the plasma. Characterization of brain-derived Evs in the blood might thus be used for diagnostic and prognostic assessment of various neurological disorders and real-time monitoring of patient responses to targeted therapies. However, current techniques for evaluating brain-derived EVs in CSF and blood face challenges due to the need for sensitive and specific isolation methods. Subsequently, there is an urgent need to standardize brain-derived EV isolation and identification methods to support efficient disease diagnosis (Figure 1C) (Sandau et al., 2024). Nevertheless, while research into brain-derived EVs in the context of virus-induced neurological diseases is still in its infancy, it holds significant promise as EVs 1) could serve as valuable sources of information that can help to elucidate intricate cellular processes within an inaccessible organ such as the brain and 2) hold promise for advancing clinical diagnoses.
Figure 1 Exploring the promise of extracellular vesicles (EVs) in viral infection of the brain. EVs might play a vital role in uncovering the intricate cellular processes within an inaccessible organ such as the brain, by bridging the gap between laboratory-based discoveries and real-life observations. (A) The intricate interplay between EVs and viruses in vivo operates on a multifaced level. EVs can serve as a mean of viral propagation or act as carriers of pro- or anti-viral mediators that might contribute to neurodegeneration or breakdown of the blood-brain-barrier (BBB). (B) Improved in vitro human models are warranted to delve into the role of EVs in the propagation of neurotropic viruses and to study EV dynamics. Such models might include organoid cultures or microfluidic systems mimicking the cellular composition and microenvironment of the CNS compared to traditional cell culture models. (C) The potential of EVs to cross biological barriers provides a mean by which brain-derived EVs in the periphery can be utilized as a relevant source of information. Indeed, the elucidation of key cellular mechanisms at play in the brain during viral infection could lead to the identification of robust biomarkers using the protein, nucleic acid, or lipid EV-associated signatures that are unique to viral infections. However, challenges such as sensitive isolation methods need to be addressed for standardized and efficient disease diagnosis and monitoring, thus ultimately improving patient care. Illustration created with BioRender.com.
Author contributions
LO: Conceptualization, Writing – review & editing, Writing – original draft. RP: Writing – review & editing, Funding acquisition, Supervision. AM: Supervision, Writing – review & editing, Conceptualization, Investigation, Project administration, Visualization.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Swiss National Science Foundation (320030_179531) and a grant from the Myelin Repair Foundation.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Arakelyan, A., Fitzgerald, W., Zicari, S., Vanpouille, C., Margolis, L. (2017). Extracellular vesicles carry HIV env and facilitate Hiv infection of human lymphoid tissue. Sci. Rep. 7, 1695. doi: 10.1038/s41598-017-01739-8
Arakelyan, A., Ivanova, O., Vasilieva, E., Grivel, J. C., Margolis, L. (2015). Antigenic composition of single nano-sized extracellular blood vesicles. Nanomedicine 11, 489–498. doi: 10.1016/j.nano.2014.09.020
Arenaccio, C., Chiozzini, C., Columba-Cabezas, S., Manfredi, F., Affabris, E., Baur, A., et al. (2014). Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism. J. Virol. 88, 11529–11539. doi: 10.1128/JVI.01712-14
Baglio, S. R., Van Eijndhoven, M. A., Koppers-Lalic, D., Berenguer, J., Lougheed, S. M., Gibbs, S., et al. (2016). Sensing of latent EBV infection through exosomal transfer of 5’pppRNA. Proc. Natl. Acad. Sci. U.S.A. 113, E587–E596. doi: 10.1073/pnas.1518130113
Bahram Sangani, N., Gomes, A. R., Curfs, L. M. G., Reutelingsperger, C. P. (2021). The role of Extracellular Vesicles during CNS development. Prog. Neurobiol. 205, 102124. doi: 10.1016/j.pneurobio.2021.102124
Bakhti, M., Winter, C., Simons, M. (2011). Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosome-like vesicles. J. Biol. Chem. 286, 787–796. doi: 10.1074/jbc.M110.190009
Bárbara, A., Sónia, A. M. (2017). “Animal models in exosomes research: what the future holds,” in Novel Implications of Exosomes in Diagnosis and Treatment of Cancer and Infectious Diseases. Ed. Jin, W. (IntechOpen, Rijeka)
Bello-Morales, R., Praena, B., De La Nuez, C., Rejas, M. T., Guerra, M., Galan-Ganga, M., et al. (2018). Role of microvesicles in the spread of herpes simplex virus 1 in oligodendrocytic cells. J. Virol. 92 (10). doi: 10.1128/JVI.00088-18
Bello-Morales, R., Ripa, I., Lopez-Guerrero, J. A. (2020). Extracellular vesicles in viral spread and antiviral response. Viruses 12 (6), 623. doi: 10.3390/v12060623
Boukouris, S., Mathivanan, S. (2015). Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin. Appl. 9, 358–367. doi: 10.1002/prca.201400114
Brasil, P., Pereira, J. P., Jr., Moreira, M. E., Ribeiro Nogueira, R. M., Damasceno, L., Wakimoto, M., et al. (2016). Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375, 2321–2334. doi: 10.1056/NEJMoa1602412
Buzas, E. I. (2022). Opportunities and challenges in studying the extracellular vesicle corona. Nat. Cell Biol. 24, 1322–1325. doi: 10.1038/s41556-022-00983-z
Clayton, A., Boilard, E., Buzas, E. I., Cheng, L., Falcón-Perez, J. M., Gardiner, C., et al. (2019). Considerations towards a roadmap for collection, handling and storage of blood extracellular vesicles. J. Extracell Vesicles 8, 1647027. doi: 10.1080/20013078.2019.1647027
Colombo, M., Raposo, G., Thery, C. (2014). Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255–289. doi: 10.1146/annurev-cellbio-101512-122326
Cortese, I., Reich, D. S., Nath, A. (2021). Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease. Nat. Rev. Neurol. 17, 37–51. doi: 10.1038/s41582-020-00427-y
Cugola, F. R., Fernandes, I. R., Russo, F. B., Freitas, B. C., Dias, J. L. M., Guimarães, K. P., et al. (2016). The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267–271. doi: 10.1038/nature18296
de Menezes, E. G. M., Liu, J. S., Bowler, S. A., Giron, L. B., D'antoni, M. L., Shikuma, C. M., et al. (2022). Circulating brain-derived extracellular vesicles expressing neuroinflammatory markers are associated with HIV-related neurocognitive impairment. Front. Immunol. 13, 1033712. doi: 10.3389/fimmu.2022.1033712
Deschamps, T., Kalamvoki, M. (2018). Extracellular vesicles released by herpes simplex virus 1-infected cells block virus replication in recipient cells in a STING-dependent manner. J. Virol. 92 (18). doi: 10.1128/JVI.01102-18
Doyle, L. M., Wang, M. Z. (2019). Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 8 (7), 727. doi: 10.3390/cells8070727
Dreux, M., Garaigorta, U., Boyd, B., Decembre, E., Chung, J., Whitten-Bauer, C., et al. (2012). Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12, 558–570. doi: 10.1016/j.chom.2012.08.010
Edlund, T., Jessell, T. M. (1999). Progression from extrinsic to intrinsic signaling in cell fate specification: a view from the nervous system. Cell 96, 211–224. doi: 10.1016/S0092-8674(00)80561-9
Feng, Z., Hensley, L., Mcknight, K. L., Hu, F., Madden, V., Ping, L., et al. (2013). A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 496, 367–371. doi: 10.1038/nature12029
Fruhbeis, C., Frohlich, D., Kramer-Albers, E. M. (2012). Emerging roles of exosomes in neuron-glia communication. Front. Physiol. 3, 119. doi: 10.3389/fphys.2012.00119
Gandham, S., Su, X., Wood, J., Nocera, A. L., Alli, S. C., Milane, L., et al. (2020). Technologies and standardization in research on extracellular vesicles. Trends Biotechnol. 38, 1066–1098. doi: 10.1016/j.tibtech.2020.05.012
Goetzl, E. J., Boxer, A., Schwartz, J. B., Abner, E. L., Petersen, R. C., Miller, B. L., et al. (2015). Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85, 40–47. doi: 10.1212/WNL.0000000000001702
Goetzl, E. J., Schwartz, J. B., Abner, E. L., Jicha, G. A., Kapogiannis, D. (2018). High complement levels in astrocyte-derived exosomes of Alzheimer disease. Ann. Neurol. 83, 544–552. doi: 10.1002/ana.25172
Görgens, A., Corso, G., Hagey, D. W., Jawad Wiklander, R., Gustafsson, M. O., Felldin, U., et al. (2022). Identification of storage conditions stabilizing extracellular vesicles preparations. J. Extracell Vesicles 11, e12238. doi: 10.1002/jev2.12238
Graykowski, D. R., Wang, Y. Z., Upadhyay, A., Savas, J. N. (2020). The dichotomous role of extracellular vesicles in the central nervous system. iScience 23, 101456. doi: 10.1016/j.isci.2020.101456
Guha, D., Lorenz, D. R., Misra, V., Chettimada, S., Morgello, S., Gabuzda, D. (2019). Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment. J. Neuroinflamm. 16, 254. doi: 10.1186/s12974-019-1617-y
Hallal, S. M., Tűzesi, Á., Sida, L. A., Xian, E., Madani, D., Muralidharan, K., et al. (2024). Glioblastoma biomarkers in urinary extracellular vesicles reveal the potential for a ‘liquid gold’ biopsy. Br. J. Cancer 130, 836–851. doi: 10.1038/s41416-023-02548-9
Harding, C., Heuser, J., Stahl, P. (1984). Endocytosis and intracellular processing of transferrin and colloidal gold-transferrin in rat reticulocytes: demonstration of a pathway for receptor shedding. Eur. J. Cell Biol. 35, 256–263.
He, J., Ren, W., Wang, W., Han, W., Jiang, L., Zhang, D., et al. (2022). Exosomal targeting and its potential clinical application. Drug Deliv. Trans. Res. 12, 2385–2402. doi: 10.1007/s13346-021-01087-1
Heilingloh, C. S., Kummer, M., Muhl-Zurbes, P., Drassner, C., Daniel, C., Klewer, M., et al. (2015). L particles transmit viral proteins from herpes simplex virus 1-infected mature dendritic cells to uninfected bystander cells, inducing CD83 downmodulation. J. Virol. 89, 11046–11055. doi: 10.1128/JVI.01517-15
Hendrix, A. (2021). The nature of blood(y) extracellular vesicles. Nat. Rev. Mol. Cell Biol. 22, 243–243. doi: 10.1038/s41580-021-00348-8
Hill, A. F., Pegtel, D. M., Lambertz, U., Leonardi, T., O'driscoll, L., Pluchino, S., et al. (2013). ISEV position paper: extracellular vesicle RNA analysis and bioinformatics. J. Extracell Vesicles 2, 22859. doi: 10.3402/jev.v2i0.22859
Hu, G., Niu, F., Liao, K., Periyasamy, P., Sil, S., Liu, J., et al. (2012). Exosome-mediated shuttling of microRNA-29 regulates HIV Tat and morphine-mediated neuronal dysfunction. Cell Death Dis. 3, e381. doi: 10.1038/cddis.2012.114
Hu, G., Yao, H., Chaudhuri, A. D., Duan, M., Yelamanchili, S. V., Wen, H., et al. (2020). HIV-1 tat-induced astrocytic extracellular vesicle miR-7 impairs synaptic architecture. J. Neuroimmune Pharmacol. 15, 538–553. doi: 10.1007/s11481-019-09869-8
Johnstone, R. M., Adam, M., Hammond, J. R., Orr, L., Turbide, C. (1987). Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J. Biol. Chem. 262, 9412–9420. doi: 10.1016/S0021-9258(18)48095-7
Khatua, A. K., Taylor, H. E., Hildreth, J. E., Popik, W. (2009). Exosomes packaging APOBEC3G confer human immunodeficiency virus resistance to recipient cells. J. Virol. 83, 512–521. doi: 10.1128/JVI.01658-08
Konadu, K. A., Huang, M. B., Roth, W., Armstrong, W., Powell, M., Villinger, F., et al. (2016). Isolation of exosomes from the plasma of HIV-1 positive individuals. J. Vis. Exp. 107, 53495. doi: 10.3791/53495
Kramer-Albers, E. M., Hill, A. F. (2016). Extracellular vesicles: interneural shuttles of complex messages. Curr. Opin. Neurobiol. 39, 101–107. doi: 10.1016/j.conb.2016.04.016
Kutchy, N. A., Peeples, E. S., Sil, S., Liao, K., Chivero, E. T., Hu, G., et al. (2020). Extracellular vesicles in viral infections of the nervous system. Viruses 12 (7), 700. doi: 10.3390/v12070700
Lim, W. Q., Michelle Luk, K. H., Lee, K. Y., Nurul, N., Loh, S. J., Yeow, Z. X., et al. (2023). Small extracellular vesicles’ miRNAs: biomarkers and therapeutics for neurodegenerative diseases. Pharmaceutics 15 (4), 1216. doi: 10.3390/pharmaceutics15041216
Liu, H., Wang, J., Chen, Y., Chen, Y., Ma, X., Bihl, J. C., et al. (2017). NPC-EXs Alleviate Endothelial Oxidative Stress and Dysfunction through the miR-210 Downstream Nox2 and VEGFR2 Pathways. Oxid. Med. Cell Longev. 2017, 9397631. doi: 10.1155/2017/9397631
Lo Cicero, A., Stahl, P. D., Raposo, G. (2015). Extracellular vesicles shuffling intercellular messages: for good or for bad. Curr. Opin. Cell Biol. 35, 69–77. doi: 10.1016/j.ceb.2015.04.013
Lucien, F., Gustafson, D., Lenassi, M., Li, B., Teske, J. J., Boilard, E., et al. (2023). MIBlood-EV: Minimal information to enhance the quality and reproducibility of blood extracellular vesicle research. J. Extracell Vesicles 12, 12385. doi: 10.1002/jev2.12385
Marcocci, M. E., Napoletani, G., Protto, V., Kolesova, O., Piacentini, R., Li Puma, D. D., et al. (2020). Herpes simplex virus-1 in the brain: the dark side of a sneaky infection. Trends Microbiol. 28, 808–820. doi: 10.1016/j.tim.2020.03.003
Meckes, D. G., Jr., Gunawardena, H. P., Dekroon, R. M., Heaton, P. R., Edwards, R. H., Ozgur, S., et al. (2013). Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc. Natl. Acad. Sci. U.S.A. 110, E2925–E2933. doi: 10.1073/pnas.1303906110
Minciacchi, V. R., Freeman, M. R., Di Vizio, D. (2015). Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin. Cell Dev. Biol. 40, 41–51. doi: 10.1016/j.semcdb.2015.02.010
Morris-Love, J., Gee, G. V., O'hara, B. A., Assetta, B., Atkinson, A. L., Dugan, A. S., et al. (2019). JC polyomavirus uses extracellular vesicles to infect target cells. mBio 10 (2), e00379–19. doi: 10.1128/mBio.00379-19
Morris-Love, J., O'hara, B. A., Gee, G. V., Dugan, A. S., O'rourke, R. S., Armstead, B. E., et al. (2022). Biogenesis of JC polyomavirus associated extracellular vesicles. J. Extracell Biol. 1 (5), e43. doi: 10.1002/jex2.43
Moulin, C., Crupi, M. J. F., Ilkow, C. S., Bell, J. C., Boulton, S. (2023). Extracellular vesicles and viruses: two intertwined entities. Int. J. Mol. Sci. 24 (2), 1036. doi: 10.3390/ijms24021036
Mukherjee, S., Akbar, I., Kumari, B., Vrati, S., Basu, A., Banerjee, A. (2019). Japanese Encephalitis Virus-induced let-7a/b interacted with the NOTCH-TLR7 pathway in microglia and facilitated neuronal death via caspase activation. J. Neurochem. 149, 518–534. doi: 10.1111/jnc.14645
Nagashima, S., Jirintai, S., Takahashi, M., Kobayashi, T., Tanggis, Nishizawa, T., et al. (2014). Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies. J. Gen. Virol. 95, 2166–2175. doi: 10.1099/vir.0.066910-0
Nolte-’t Hoen, E. N., Van Der Vlist, E. J., Aalberts, M., Mertens, H. C., Bosch, B. J., Bartelink, W., et al. (2012). Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles. Nanomedicine 8, 712–720. doi: 10.1016/j.nano.2011.09.006
Nolte-’t Hoen, E., Cremer, T., Gallo, R. C., Margolis, L. B. (2016). Extracellular vesicles and viruses: Are they close relatives? Proc. Natl. Acad. Sci. U.S.A. 113, 9155–9161. doi: 10.1073/pnas.1605146113
Norman, M., Ter-Ovanesyan, D., Trieu, W., Lazarovits, R., Kowal, E. J. K., Lee, J. H., et al. (2021). L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma. Nat. Methods 18, 631–634. doi: 10.1038/s41592-021-01174-8
Oberholster, L., Mathias, A., Perriot, S., Blaser, E., Canales, M., Jones, S., et al. (2023). Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles. Microbiol. Spectr. 11, e0275123. doi: 10.1128/spectrum.02751-23
O’Hara, B. A., Morris-Love, J., Gee, G. V., Haley, S. A., Atwood, W. J. (2020). JC Virus infected choroid plexus epithelial cells produce extracellular vesicles that infect glial cells independently of the virus attachment receptor. PloS Pathog. 16, e1008371. doi: 10.1371/journal.ppat.1008371
Ohmichi, T., Mitsuhashi, M., Tatebe, H., Kasai, T., Ali El-Agnaf, O. M., Tokuda, T. (2019). Quantification of brain-derived extracellular vesicles in plasma as a biomarker to diagnose Parkinson’s and related diseases. Parkinsonism Relat. Disord. 61, 82–87. doi: 10.1016/j.parkreldis.2018.11.021
Padgett, B. L., Walker, D. L., Zurhein, G. M., Eckroade, R. J., Dessel, B. H. (1971). Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1, 1257–1260. doi: 10.1016/S0140-6736(71)91777-6
Pan, B. T., Teng, K., Wu, C., Adam, M., Johnstone, R. M. (1985). Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell Biol. 101, 942–948. doi: 10.1083/jcb.101.3.942
Perez, P. S., Romaniuk, M. A., Duette, G. A., Zhao, Z., Huang, Y., Martin-Jaular, L., et al. (2019). Extracellular vesicles and chronic inflammation during HIV infection. J. Extracell Vesicles 8, 1687275. doi: 10.1080/20013078.2019.1687275
Raghav, A., Singh, M., Jeong, G. B., Giri, R., Agarwal, S., Kala, S., et al. (2022). Extracellular vesicles in neurodegenerative diseases: A systematic review. Front. Mol. Neurosci. 15, 1061076. doi: 10.3389/fnmol.2022.1061076
Ramakrishnaiah, V., Thumann, C., Fofana, I., Habersetzer, F., Pan, Q., De Ruiter, P. E., et al. (2013). Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc. Natl. Acad. Sci. U.S.A. 110, 13109–13113. doi: 10.1073/pnas.1221899110
Ramos-Zaldivar, H. M., Polakovicova, I., Salas-Huenuleo, E., Corvalan, A. H., Kogan, M. J., Yefi, C. P., et al. (2022). Extracellular vesicles through the blood-brain barrier: a review. Fluids Barriers CNS 19, 60. doi: 10.1186/s12987-022-00359-3
Raposo, G., Nijman, H. W., Stoorvogel, W., Liejendekker, R., Harding, C. V., Melief, C. J., et al. (1996). B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 183, 1161–1172. doi: 10.1084/jem.183.3.1161
Raymond, A. D., Diaz, P., Chevelon, S., Agudelo, M., Yndart-Arias, A., Ding, H., et al. (2016). Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides. J. Neurovirol 22, 129–139. doi: 10.1007/s13365-015-0397-0
Robinson, S. M., Tsueng, G., Sin, J., Mangale, V., Rahawi, S., Mcintyre, L. L., et al. (2014). Coxsackievirus B exits the host cell in shed microvesicles displaying autophagosomal markers. PloS Pathog. 10, e1004045. doi: 10.1371/journal.ppat.1004045
Roux, Q., Van Deun, J., Dedeyne, S., Hendrix, A. (2020). The EV-TRACK summary add-on: integration of experimental information in databases to ensure comprehensive interpretation of biological knowledge on extracellular vesicles. J. Extracell Vesicles 9, 1699367. doi: 10.1080/20013078.2019.1699367
Sami Saribas, A., Cicalese, S., Ahooyi, T. M., Khalili, K., Amini, S., Sariyer, I. K. (2017). HIV-1 Nef is released in extracellular vesicles derived from astrocytes: evidence for Nef-mediated neurotoxicity. Cell Death Dis. 8, e2542. doi: 10.1038/cddis.2016.467
Sandau, U. S., Magana, S. M., Costa, J., Nolan, J. P., Ikezu, T., Vella, L. J., et al. (2024). Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies. J. Extracell Vesicles 13, 7, e1239. doi: 10.1002/jev2.12397
Santiana, M., Ghosh, S., Ho, B. A., Rajasekaran, V., Du, W. L., Mutsafi, Y., et al. (2018). Vesicle-cloaked virus clusters are optimal units for inter-organismal viral transmission. Cell Host Microbe 24, 208–220.e8. doi: 10.1016/j.chom.2018.07.006
Saugstad, J. A., Lusardi, T. A., Van Keuren-Jensen, K. R., Phillips, J. I., Lind, B., Harrington, C. A., et al. (2017). Analysis of extracellular RNA in cerebrospinal fluid. J. Extracell Vesicles 6, 1317577. doi: 10.1080/20013078.2017.1317577
Scribano, S., Guerrini, M., Arvia, R., Guasti, D., Nardini, P., Romagnoli, P., et al. (2020). Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples. J. Clin. Virol. 128, 104435. doi: 10.1016/j.jcv.2020.104435
Sharma, P., Mesci, P., Carromeu, C., Mcclatchy, D. R., Schiapparelli, L., Yates, J. R., 3rd, et al. (2019). Exosomes regulate neurogenesis and circuit assembly. Proc. Natl. Acad. Sci. U.S.A. 116, 16086–16094. doi: 10.1073/pnas.1902513116
Solana-Balaguer, J., Campoy-Campos, G., Martin-Flores, N., Perez-Sisques, L., Sitja-Roqueta, L., Kucukerden, M., et al. (2023). Neuron-derived extracellular vesicles contain synaptic proteins, promote spine formation, activate TrkB-mediated signalling and preserve neuronal complexity. J. Extracell Vesicles 12, e12355. doi: 10.1002/jev2.12355
Sun, B., Dalvi, P., Abadjian, L., Tang, N., Pulliam, L. (2017). Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV. AIDS 31, F9–F17. doi: 10.1097/QAD.0000000000001595
Sun, G., Kropp, K. A., Kirchner, M., Pluckebaum, N., Selich, A., Serrero, M., et al. (2024). Herpes simplex virus type 1 modifies the protein composition of extracellular vesicles to promote neurite outgrowth and neuroinfection. mBio 15, e0330823. doi: 10.1128/mbio.03308-23
Swearengen, J. R. (2018). Choosing the right animal model for infectious disease research. Anim. Model. Exp. Med. 1, 100–108. doi: 10.1002/ame2.12020
Tang, N., Kido, T., Shi, J., Mccafferty, E., Ford, J. M., Dal Bon, K., et al. (2024). Blood markers show neural consequences of longCOVID-19. Cells 13 (6), 478. doi: 10.3390/cells13060478
Thery, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., et al. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell Vesicles 7, 1535750. doi: 10.1080/20013078.2018.1535750
Tricarico, C., Clancy, J., D’Souza-Schorey, C. (2017). Biology and biogenesis of shed microvesicles. Small GTPases 8, 220–232. doi: 10.1080/21541248.2016.1215283
Troyer, Z., Tilton, J. C. (2021). Extracellular vesicles as carriers of viruses. ExRNA 3, 13. doi: 10.21037/exrna
Upadhya, R., Zingg, W., Shetty, S., Shetty, A. K. (2020). Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders. J. Control Release 323, 225–239. doi: 10.1016/j.jconrel.2020.04.017
Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654–659. doi: 10.1038/ncb1596
Van Deun, J., Mestdagh, P., Agostinis, P., Akay, Ö., Anand, S., Anckaert, J., et al. (2017). EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods 14, 228–232. doi: 10.1038/nmeth.4185
Vanherle, S., Haidar, M., Irobi, J., Bogie, J. F. J., Hendriks, J. J. A. (2020). Extracellular vesicle-associated lipids in central nervous system disorders. Advanced Drug Deliv. Rev. 159, 322–331. doi: 10.1016/j.addr.2020.04.011
van Niel, G., D’Angelo, G., Raposo, G. (2018). Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213–228. doi: 10.1038/nrm.2017.125
Welsh, J. A., Goberdhan, D. C. I., O'driscoll, L., Buzas, E. I., Blenkiron, C., Bussolati, B., et al. (2024). Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches. J. Extracell Vesicles 13, e12404. doi: 10.1002/jev2.12404
Wu, H., Huang, X.-Y., Sun, M.-X., Wang, Y., Zhou, H.-Y., Tian, Y., et al. (2023). Zika virus targets human trophoblast stem cells and prevents syncytialization in placental trophoblast organoids. Nat. Commun. 14, 5541. doi: 10.1038/s41467-023-41158-0
Wu, X., Zheng, T., Zhang, B. (2017). Exosomes in parkinson’s disease. Neurosci. Bull. 33, 331–338. doi: 10.1007/s12264-016-0092-z
Xu, R., Greening, D. W., Zhu, H. J., Takahashi, N., Simpson, R. J. (2016). Extracellular vesicle isolation and characterization: toward clinical application. J. Clin. Invest. 126, 1152–1162. doi: 10.1172/JCI81129
Yanez-Mo, M., Siljander, P. R., Andreu, Z., Zavec, A. B., Borras, F. E., Buzas, E. I., et al. (2015). Biological properties of extracellular vesicles and their physiological functions. J. Extracell Vesicles 4, 27066. doi: 10.3402/jev.v4.27066
You, Y., Muraoka, S., Jedrychowski, M. P., Hu, J., Mcquade, A. K., Young-Pearse, T., et al. (2022). Human neural cell type-specific extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer’s disease brain. J. Extracell Vesicles 11, e12183. doi: 10.1002/jev2.12183
Yuyama, K., Sun, H., Sakai, S., Mitsutake, S., Okada, M., Tahara, H., et al. (2014). Decreased amyloid-beta pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice. J. Biol. Chem. 289, 24488–24498. doi: 10.1074/jbc.M114.577213
Zhang, Y., Wong, C. Y., Lim, C. Z. J., Chen, Q., Yu, Z., Natalia, A., et al. (2023). Multiplexed RNA profiling by regenerative catalysis enables blood-based subtyping of brain tumors. Nat. Commun. 14, 4278. doi: 10.1038/s41467-023-39844-0
Zhang, Z.-W., Li, Z.-L., Yuan, S. (2017). The role of secretory autophagy in zika virus transfer through the placental barrier. Front. Cell. Infect. Microbiol. 6. doi: 10.3389/fcimb.2016.00206
Zhou, W., Woodson, M., Sherman, M. B., Neelakanta, G., Sultana, H. (2019). Exosomes mediate Zika virus transmission through SMPD3 neutral Sphingomyelinase in cortical neurons. Emerg. Microbes Infect. 8, 307–326. doi: 10.1080/22221751.2019.1578188
Keywords: extracellular vesicles, neurotropic viruses, biomarker, pathogenesis, herpes simplex, polyomavirus, Zika virus, HIV
Citation: Oberholster L, Du Pasquier R and Mathias A (2024) Exploring the role of brain-derived extracellular vesicles in viral infections: from pathological insights to biomarker potential. Front. Cell. Infect. Microbiol. 14:1423394. doi: 10.3389/fcimb.2024.1423394
Received: 25 April 2024; Accepted: 21 May 2024;
Published: 03 June 2024.
Edited by:
A. Alwin Prem Anand, University of Tübingen, GermanyReviewed by:
Lucia Vojtech, University of Washington, United StatesAntje Maria Zickler, Karolinska Institutet (KI), Sweden
Copyright © 2024 Oberholster, Du Pasquier and Mathias. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Amandine Mathias, Amandine.mathias@chuv.ch